Clinical features of Staphylococcus aureus bacteraemia in children included in the study
| Focus of infection at time of bacteraemia | Pre-IDC group N=30 episodes (%) | IDC group N=36 episodes (%) | Combined N=66 episodes (%) | p Value |
|---|---|---|---|---|
| Unknown focus | 7 (23.3) | 2 (5.6) | 9 (13.6) | NS |
| Intravascular catheter | 8 (26.7) | 22 (61.3) | 30 (45.5) | 0.013 |
| Culture confirmed | 5 (62.5) | 11 (50.0) | 16 (53.3) | NS |
| Thrombophlebitis | 0 | 2 (5.7) | 2 (3.0) | NS |
| Bone/joint infection | 8 (26.7) | 8 (22.2) | 16 (24.2) | NS |
| Culture confirmed | 4 (50.0) | 2 (25.0) | 6 (37.5) | NS |
| Lung | 1 (3.3) | 1 (2.8) | 2 (3.0) | NS |
| Culture confirmed | 0 | 1 (100.0) | 1 (50) | NS |
| Skin and soft tissue | 7 (23.3) | 9 (25.0) | 16 (24.2) | NS |
| Culture confirmed | 4 (57.1) | 8 (88.9) | 12 (75.0) | NS |
| Deep tissue abscess | 2 (6.7) | 1 (2.8) | 3 (4.6) | NS |
| Culture confirmed | 2 (100.0) | 0 | 2 (66.7) | NS |
| Other focus | 2 (6.7) | 4 (11.1) | 6 (9.1) | NS |
| Defervescence at 72 h | ||||
| Yes | 18 (60.0) | 20 (55.6) | 38 (57.6) | NS |
| No | 11 (36.7) | 14 (38.9) | 25 (37.9) | |
| Unknown | 1 (3.3) | 2 (5.6) | 3 (4.6) |
IDC, infectious diseases consultation; NS, non-significant.